/
•
•
This development follows AstraZeneca admitting that its COVID-19 vaccine could cause blood clot-related side effects in ‘very rare’ cases.

In one of its worst years yet, India’s largest winemaker is facing headwinds on all fronts and has little by way of a plan.
While consulting remains the most sought-after career choice at top B-schools, the sector itself is experiencing its worst downturn in recent history.
The earnings of India’s oil refiners and other Nifty 50 companies have taken a hit. But IPO premiums suggest that investors seem unfazed.